Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07438743 · ClinicalTrials.gov registry record · NA
An Evaluation of Epic EHR AI Outpatient Chart Summarization
A NA study of Quality Improvement, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 284
- Enrollment target
- 1
- Study location
NCT07438743: Active NA study of Quality Improvement, sponsored by University of California, Los Angeles.
NCT07438743 is a NA study of Quality Improvement that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 284 participants, below the 1,317-participant average among 7 other Quality Improvement trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07438743, a NA study of Quality Improvement, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 284 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a RCT of 284 outpatient physicians at a large academic health system, randomized 1:1 to an electronic health record (EHR) produced generative AI outpatient chart summarization tool or a usual-care control group. The 90 day study will observe the effects of the tool prior to system-wide roll out of the tool.
Primary Outcome
Physician task load adapted from the NASA Task Load Index (TLX), a validated tool for assessing EHR-related cognitive task load in four sub-scales (mental demand, temporal demand, physical demand, and effort). This outcome is adapted to capture the task of pre-charting, defined for this study as the practice of reviewing patient information in the EHR before a patient visit to prepare for the encounter. Each sub-scale is rated from 0 (low) to 100 (high) and is aggregated to a 0-400 point scale.
Conditions Studied
Interventions
- OTHER GenAI Chart Summarization
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2026-02-23 |
| Est. Completion | 2026-05 |
| Phase | NA |
What the registry record for NCT07438743 still lists
NCT07438743 is an interventional study that assigns participants to a tested intervention. The registered 284 participants enrollment target is mid-sized for trials with a published cap, below the 1,317-participant average among 7 other Quality Improvement trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Quality Improvement appearing as the primary indexed condition, and to 1 intervention - of which GenAI Chart Summarization is the first listed.
NCT07438743 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07438743 about?
NCT07438743 is a clinical study titled "An Evaluation of Epic EHR AI Outpatient Chart Summarization". This is a RCT of 284 outpatient physicians at a large academic health system, randomized 1:1 to an electronic health record (EHR) produced generative AI outpatient chart summarization tool or a usual-care control group. The 90 day study will observe the effects of the tool prior to system-wide roll ...
What is the current status of trial NCT07438743?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 284 participants. The study started on 2026-02-23. Estimated completion is 2026-05.
What conditions does trial NCT07438743 study?
This clinical trial studies the following conditions: Quality Improvement.
What interventions are being tested in trial NCT07438743?
The interventions under investigation include: GenAI Chart Summarization (OTHER).
Who is sponsoring clinical trial NCT07438743?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07438743 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Quality Improvement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences
RECRUITING · NA
-
Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.
RECRUITING · NA
-
A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine
COMPLETED · NA
-
Improving Pediatric Safety and Quality With Health Care Information Technology
COMPLETED · NA
-
Testing the Reliability and Validity of the CIBA
COMPLETED
-
Enhanced Recovery After Surgery in Colorectal Surgery: A Large-Scale Quality Improvement Project
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
- NCT06963034 · 284 participants · Phase 3
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI